Advertisement
Advertisement

HIV Care Today


A Bad Note in HIV Prevention: Our VOICE May Be Hoarse, but the Opera Isn't Over
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
November 29, 2011

Another disappointing note was bellowed out this month concerning the discontinuation of part of a significant HIV prevention trial in women. The 1% tenofovir (Viread) gel arm of the VOICE phase 2B clinical trial was halted early by the independent Data and Safety Monitoring Board (DSMB).

Read more …


Under The Radar: Mental Health and HIV Risk
By David Fawcett, Ph.D., L.C.S.W.
November 22, 2011

Getting the level of new infections down to zero will require breakthroughs not only in medications and improved interventions, but also a broadening of our understanding about the underlying causes of high-risk behaviors which can increase vulnerability for HIV, specifically, mental health concerns.

Read more …


Who Should Care for the Aging HIV Patient? Everything Old Is ... Oh You Know
By Paul E. Sax, M.D.
November 21, 2011

Over in Journal Watch AIDS Clinical Care, Carlos Del Rio reviews a couple of remarkable studies on HIV and aging.

Read more …


Testosterone Replacement Therapy and Polycythemia in HIV-Infected Patients
By Nelson Vergel, B.S.Ch.E., M.B.A.
November 16, 2011

A research letter recently published in the journal AIDS by Vorkas et al determined that testosterone use was associated with polycythemia, and intramuscular administration demonstrated a stronger association than topical (testosterone patch) use. No adverse cardiovascular or thrombotic events were observed. HIV-infected patients taking testosterone should undergo routine hematologic monitoring with adjustment of therapy when appropriate.

Read more …


HCV Treatment Studies at AASLD: Wow ... and I Mean WOW!
By Paul E. Sax, M.D.
November 10, 2011

I didn't attend "The Liver Meeting" (the nickname for the annual meeting of the American Association for the Study of Liver Diseases, AASLD), but the studies presented there this week on HCV treatment were absolutely mind-boggling.

Read more …


HIV and Sexual Function in Women Over 50
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
November 8, 2011

I recently wrote a "stand-up" blog (pun intended) on erectile dysfunction in HIV-positive men over age 50, which caused a few tongues to wag. So in order to present "fair balance" between the genders, this "dictates" (oh my) that I must blog on HIV-positive women over 50 and sexual function, or lack thereof.

Read more …


I Am Tired of Watching Them Cry: Facing the Emotional Burden of HIV Stigma
By Lisa Fitzpatrick, M.D., M.P.H.
October 31, 2011

I was a new provider in the clinic, and she was one of my first patients, HIV positive for over 10 years. As I entered the exam room and saw her staring out the window, I made at least half a dozen intuitive assessments about her. She was well-dressed; clearly a strong and authoritative woman; a well-respected professional with very high standards of herself and others. As she began to share her story, I realized I was correct on all counts. Judging by the questions she asked me, I was not spared from her high expectations.

Read more …


Will An Antiretroviral Patch Help Adherence? Doubtful
By Paul E. Sax, M.D.
October 29, 2011

Preliminary research suggests that a patch could deliver an AIDS drug to patients ... The researchers successfully used transdermal patches to administer 96 percent of an AIDS drug to simulated skin over a week. "Still, the important limitation of pills, regardless of how few there are or even how minimal the side effects, is adherence," Johnston [the investigator] noted. Research has shown that many patients, if not most, don't take their pills all the time.

Read more …


"Supersized Alcopops": The Dangers of Excessive Alcohol Consumption for People Living With HIV
By David Fawcett, Ph.D., L.C.S.W.
October 27, 2011

Public apprehension about recreational drugs, especially those that impact HIV, seems to come in waves that swell with increasing alarm and then peak and fade away, always to be replaced by the next "drug du jour." Heroin, cocaine, and methamphetamine, each with a well-deserved reputation for putting people at risk for HIV or, if HIV positive, for interfering with their ability to properly manage their health, have all gained notoriety in recent years.

Read more …


Going, Going, Gone ... HIV Treatment Failure Is Disappearing in People Who Take Their Meds
By Paul E. Sax, M.D.
October 19, 2011

World Series time, hence the baseball reference in the title. (Doesn't take much.) But over in Lancet Infectious Diseases -- which has turned out to be a terrific journal, by the way -- there's a study reminding us that advances in HIV treatment in the late 2000s were truly spectacular.

Read more …

 < Prev  |  1  |  …  |  8  |  9  |  10  |  11  |  12  |  …  |  15  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.com.
 

Advertisement